Cargando…
SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study
Clinical observations suggest that incidence of cough in Chinese taking angiotensin converting enzyme inhibitors is much higher than other racial groups. Cough is the most common adverse reaction of enalapril. We investigate whether SLCO1B1 genetic polymorphisms, previously reported to be important...
Autores principales: | Luo, Jian-Quan, He, Fa-Zhong, Wang, Zhen-Min, Sun, Ning-Ling, Wang, Lu-Yan, Tang, Gen-Fu, Liu, Mou-Ze, Li, Qing, Chen, Xiao-Ping, Liu, Zhao-Qian, Zhou, Hong-Hao, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660479/ https://www.ncbi.nlm.nih.gov/pubmed/26607661 http://dx.doi.org/10.1038/srep17253 |
Ejemplares similares
-
The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril
por: Watanabe, Machiko, et al.
Publicado: (2015) -
Inhibition of central angiotensin-converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat
por: Panahpour, H., et al.
Publicado: (2010) -
Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
por: Li, Qian, et al.
Publicado: (2019) -
Recoverability of renal function after relief of chronic partial unilateral ureteric obstruction: The effect of an angiotensin-converting enzyme inhibitor (enalapril)
por: Soliman, Shady A., et al.
Publicado: (2011) -
Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study
por: Yao, Taikang, et al.
Publicado: (2023)